Welcome to ISV Congress Website!

Dear ISV Members, Colleagues, and Friends,

We are excited to announce that the upcoming International Society for Vaccines (ISV) Annual
Congress will be held in Lausanne, Switzerland, at the SwissTech Convention Center on
October 22-24, 2023. The ISV Congress The 2023 ISV Annual Congress welcomes delegates
from all over the world to present and discuss the latest insights in Vaccinology.

The SwissTech Convention Center is in the Lake Geneva region, in the western part of Switzerland,
close to historical Lausanne. Lausanne is easily accessible by public transport from close by
Geneva airport, which has direct flight connections to Paris, London, Brussels, Berlin, and Madrid.
Lausanne boasts one of the highest concentrations of research centers in Switzerland. A place of knowledge, innovation, and creativity, the city is home to several world-renowned researchers of many disciplines including vaccinology, immunotherapeutics, cancer, infectious diseases, artificial intelligence, and many more. In addition, the Lausanne region is home to leading small, medium, and large pharmaceutical enterprises.  Whether from academia, clinical research, or pharma and biotech, the comprehensive and vibrant scientific environment will provide an exciting venue to ISV attendees. The 2023 Congress is co-chaired by Xavier Saelens, Ken Ishii, Bruno Correia, and Giuseppe Pantaleo. 


Read More


Abstract Submission is OPEN 

Registration is OPEN 

Virtual Tickets Available   

Sponsors and Exhibitors Welcome!

ISV Main Site 

2023 CONGRESS CHAIRS

  • Xavier Saelens
    Congress Co-Chair
    VIB-Ghent University - Belgium
  • Ken Ishii
    Congress Co-Chair
    University of Tokyo - Japan
  • Bruno Correia
    Congress Co-Chair
    École Polytechnique Fédérale de Lausanne - Switzerland
  • Giuseppe Pantaleo
    Congress Co-Chair
    Swiss Vaccine Research Institute - Switzerland







2023 Confirmed Speakers

( More to be add )

  • Aleksandar Antanasijevic
    EPFL, Switzerland
  • Soumya Badrinath
    Novartis, USA
  • Dan Barouch
    Harvard, USA
  • Eva Bartok
    Institute of Tropical Medicine, Belgium
  • Grace Chen
    Moderna, USA
  • Ilse DeCoster
    University of Antwerp, Belgium
  • Lelia Delamarre
    Genentech, USA
  • Mustafa Diken
    BioNTech Immunotherapy Development Center, Germany
  • Yvonne Genzel
    Max-Planck-Institut, Germany
  • Tim Hirst
    GPN Vaccines, Australia
  • Ashraf S. Ibrahim
    Lundquist Institute for Biomedical Innovation, USA
  • Karin Jooss
    Gritstone bio, Inc., USA
  • Garnett Kelsoe
    Duke University, USA
  • Mahesh Kumar
    Zoetis, USA
  • Jason McLellan
    University of Texas, Austin, USA
  • Paul Offit
    University of Pennsylvania, USA
  • Peter Openshaw
    Imperial College, London
  • Albert (Ab) Osterhaus
    Stiftung Tierärztliche Hochschule Hannover (TiHo), Germany
  • Waranyoo Phoochareon
    Chulalongkorn University Bangkok Thailand / Baiya Phytopharm Co., Ltd, Thailand
  • Gorben Pijlman
    Wageningen University, Netherlands
  • Rino Rappuoli
    Biotecnopolo di Siena Foundation, Italy
  • Erica Ollmann Saphire
    La Jolla Institute for Immunology, USA
  • Melanie Saville
    The Coalition for Epidemic Preparedness Innovations, UK
  • Kena Swanson
    Pfizer, USA
  • David Tarlinton
    Monash University, Australia
  • David Veesler
    Washington University, USA
  • Hedda Wardemann
    German Cancer Research Center, Germany

2023 Scientific Committee

  • Cevayir Coban, University of Tokyo - Japan
  • Lisa Ng, National University of Singapore - Singapore
  • Kai Dallmeier, Ku Leuven - Belgium
  • Giuseppe Pantaleo, Swiss Vaccine Research Institute - Switzerland
  • Denise Doolan, James Cook University - Australia
  • Joon Haeng Rhee, Chonnam National University Medical School - Korea
  • Sarah Gilbert, Jenner Institute - UK
  • Ed Rybicki, University of Cape Town - South Africa
  • Linda Klavinskis, King’s College London - UK
  • Melanie Saville, CEPI - UK
  • Peter Kwong, NIH/VRC - USA
  • Yoshimasa Takahashi, National Institute of Infectious Diseases - Japan
  • Yasuko Mori, Kobe University Graduate School of Medicine - Japan
  • Tonya Villafana, MedImmune - USA
  • Past Congresses



    ISV COVID-19 & SPECIALTY VIRTUAL CONGRESSES

    Click Here

    2023 Partners & Sponsors

    2023 PARTNERS & SPONSORS

    Partners:

    ISV Congress

    Attendees

    Speakers

    Sponsors

    Countries

    2023 Congress Photos